Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
We will be testing a specific dietary supplement, methylcobalamin (vitamin B12). Follow-up
assessments with our clinical team will take place over the 12-week study period so that we
can record any changes in development. The main goal of this study is to determine if
subcutaneous injections of vitamin B12 given every three days can positively affect behavior
and development in children with autism.
Hypothesis: Methylcobalamin injections will improve measures of executive function, speech,
and socialization in children with autism, and will be associated with metabolic improvement.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of California, Davis University of California, San Francisco